CV and mad panic behaviour

[Thryleon]

So, so true. Beware the Trump magic vaccine, coming to you direct from the Nick Riviera centre for infectious disease.

Id be wary of any vaccine at the moment.  Without knowing a lot about vaccines, or without being an expert on infectious diseases its unfathomable to me, that we would green light a vaccine for 25 million people on the current data.  our infection rate is low.  The cure could cause more issues than the disease.

I notice the Oxford Vaccine has been pout on hold after a serious allergic reaction or side-effect suffered by a trial participant. These sorts of delays usually add months, and if not understood it can lead to a trial being cancelled, it'll be interesting to see what sort of impact it has in the current urgent environment.

This is typical, and why it is very wise to be nervous or sceptical of rushed solutions.

You know, to quote trump, this might just be fake news?

I.e.  they release a "set back" publically.  Then when they announce that its a false alarm, its supposed to instill confidence that the appropriate checks and balances are being followed.

Yet:

https://www.statnews.com/2020/09/08/astr...n-the-u-k/

In a follow-up statement, AstraZeneca said it initiated the study hold. The nature of the adverse reaction and when it happened were not immediately known, though the participant is expected to recover, according to an individual familiar with the matter.

advertisement

The spokesperson described the pause as “a routine action which has to happen whenever there is a potentially unexplained illness in one of the trials, while it is investigated, ensuring we maintain the integrity of the trials.” The spokesperson also said that the company is “working to expedite the review of the single event to minimize any potential impact on the trial timeline.”

An individual familiar with the development said researchers had been told the hold was placed on the trial out of “an abundance of caution.” A second individual familiar with the matter, who also spoke on condition of anonymity, said the finding is having an impact on other AstraZeneca vaccine trials underway — as well as on the clinical trials being conducted by other vaccine manufacturers.